Ethereum's (CRYPTO: ETH) lackluster performance dampened traders’ enthusiasm for the asset, but better price action is forecasted for the upcoming months.
Sharps Technology shares are trading higher Thursday after the company announced it has received a signed $30 million purchase order from Nephron Pharmaceuticals. Here's a look at the details: